Huae Xu

机构：China Pharmaceutical University, Nanjing Medical University · ORCID：0000-0001-9124-303X

发表论文 88 篇 · 总被引 2558 次 · h-index 30

代表论文

• Elastase-targeting biomimic nanoplatform for neurovascular remodeling by inhibiting NETosis mediated AlM2 inflammasome activation in ischemic stroke (2024 · Journal of Controlled Release · 被引 32)
• A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal cord injury therapy (2024 · Materials Today Bio · 被引 18)
• Dendritic Polylysine with Paclitaxel and Triptolide Codelivery for Enhanced Cancer Ferroptosis through the Accumulation of ROS (2024 · ACS Applied Materials & Interfaces · 被引 18)
• Tumor vasculature associated nanomedicine strategies (2024 · Coordination Chemistry Reviews · 被引 14)
• Angiopep-2 conjugated biomimetic nano-delivery system loaded with resveratrol for the treatment of methamphetamine addiction (2024 · International Journal of Pharmaceutics · 被引 13)
• ROS responsive hydrogel for inhibition of MUC5AC against allergic rhinitis: A new delivery strategy for Ipratropium Bromide (2024 · Colloids and Surfaces B Biointerfaces · 被引 12)